Share on LinkedInShare on LinkedIn

ARTICLE · 01 MARCH 2024

Long COVID'– The Latest Developments

Weightmans LLP
Weightmans LLP
Contributor
Weightmans LLP

Weightmans LLP

Weightmans is an award-winning UK law firm, employing more than 1,500 people. The firm has grown...

View firm profile
Explore more from Weightmans LLP

The broad clinical consensus remains that the most effective treatment will be bespoke and targeted towards the patient's individual phenotype.

United KingdomCoronavirus (COVID-19)

The broad clinical consensus remains that the most effective treatment will be bespoke and targeted towards the patient's individual phenotype.

With data from the Office of National Statistics (ONS), showing almost two million people in the UK experiencing self-reported Long COVID symptoms – defined as symptoms continuing for more than four weeks after the first confirmed or suspected COVID-19 infection - we examine both the latest medical research and developments in personal injury litigation.

Litigation against hospital trusts

Although many commentators feared that the COVID-19 pandemic would provoke an avalanche of personal injury lawsuits against employers and public bodies, litigation has been sparse with many claimants seemingly deterred by the difficulties in establishing that their condition had arisen due to occupational exposure as opposed to contraction of COVID-19 outside the workplace.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from